FDA-Drug2024-01-03Class II
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
CARDINAL HEALTHCARE
Hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Sold states
Nationwide USA
Affected count
1 unit
Manufactured in
7200 Cardinal Pl W, Dublin, OH, United States
Products
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0189-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief